The market expectation for phototherapy beds (sometimes known as red light therapy bed, low level laser therapy bed and photo biomodulation bed) is positive, as they are widely used in the medical industry for various skin conditions such as psoriasis, eczema, and neonatal jaundice. With the increasing incidence of skin conditions and the growing awareness of phototherapy as a safe and effective treatment option, the demand for phototherapy beds is expected to increase.
The main application domain for phototherapy beds is in dermatology and pediatrics. In dermatology, they are used to treat a variety of skin conditions such as psoriasis, eczema, vitiligo, and more. In pediatrics, they are used to treat neonatal jaundice, which is a common condition in newborns where their skin and eyes appear yellow due to an excess of bilirubin in the blood.
Phototherapy beds are also used in other medical fields such as rheumatology, neurology, and psychiatry, where they are used to treat conditions such as rheumatoid arthritis, seasonal affective disorder (SAD), and more.
Phototherapy beds are currently very common in the global market, expecially in developed countries. Some of the major markets include the United States, Europe, Japan, Australia, and Singapore, among others.
In China, the phototherapy bed market is growing rapidly, and with the rapid development of the healthcare industry and people’s focus on healthy lifestyles, it is expected that the phototherapy bed market will continue to grow in the next few years.
Similarly, in South Africa, India, Brazil and other developing countries, the phototherapy bed market is gradually growing and is expected to achieve rapid growth in the next few years.
Overall, phototherapy beds are expectation to have a bright future in the medical industry, with a growing demand for their use in various medical fields and applications, the market is spread across the globe, especially in developed and rapidly developing countries.